Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Natural nanoscopic particles identified as possible diagnostic tool for Alzheimer's

Exosomes are natural nanoscopic particles released by most cell types, and are currently the focus of research because they represent a possible tool for the diagnosis of Alzheimer's. These particles are not so easy to isolate, and nanotechnology may help in this process.

3 Oct 2018

Newly discovered protein shown to cause amyloid-beta plaques in Alzheimer's

Scientists have discovered that a potassium channel called KCNB1 can trigger the formation of amyloid-beta plaques seen in Alzheimer's disease.

2 Oct 2018

Half of all women are at risk of a stroke, dementia or Parkinson’s disease says study

A new study has revealed that half of all women and a third of all men are at risk of developing degenerative dementia, Parkinson’s disease or stroke.

2 Oct 2018

Study finds disease-causing mutation in French-Canadians

A team of Canadian scientists, including researchers at the Montreal Neurological Institute and Hospital has discovered the first French-Canadian founder mutation gene linked to synucleinopathies, a group of neurodegenerative diseases that includes Parkinson's disease, dementia with Lewy-Bodies and multiple system atrophy

1 Oct 2018

Mediterranean diet cuts risk of developing AMD

Evidence is mounting that a poor diet plays an important role in the development of age-related macular degeneration, a leading cause of blindness in the United States.

1 Oct 2018

More people show interest in getting their DNA tested, finds new poll

Only a small percentage of people in their 50s and early 60s have had their DNA tested - either for medical reasons, to learn their ancestry or out of curiosity - but far more have an interest in getting such tests done, according to a new poll.

1 Oct 2018

Many Alzheimer's patients are taking two or more psychotropic drugs

Up to 50% of people with Alzheimer’s disease now take a psychotropic drug and one-fifth use a combination of two or more psychotropic drugs.

1 Oct 2018

Up to half of people with Alzheimer's disease use psychotropic drug, finds study

Up to half of people with Alzheimer's disease use a psychotropic drug, and one in five uses two or more psychotropics concomitantly, according to a study conducted at the University of Eastern Finland.

1 Oct 2018

EU countries lack capacity to rapidly move future Alzheimer's treatment into clinical use

The health care systems in some European countries lack the capacity to rapidly move a disease-modifying treatment for Alzheimer's disease from approval into widespread clinical use, which could leave 1 million people without access to transformative care if such a breakthrough occurs, according to a new RAND Corporation study.

1 Oct 2018

SDSU receives $4M grant to boost number of Latino researchers studying Alzheimer's disease

The National Institute on Aging has awarded scientists at University of California San Diego School of Medicine and San Diego State University with a five-year, $4 million grant to boost the number of Latino and other underrepresented minority researchers studying Alzheimer's disease and related dementias afflicting seniors of Latino origins, a demographic historically overlooked.

29 Sep 2018

Insilico Medicine collaborates with MAWI to develop multi-modal biomarkers of aging

Cardiovascular disease is the leading cause of death and disability in the world. On the eve of the annual World Heart Day, September 29th, Insilico Medicine, Inc., a Rockville-based next-generation artificial intelligence company specializing in the application of deep learning for target identification, drug discovery and aging research announced a research collaboration agreement with MAWI, the next-generation consumer and clinical wearable company, the developer of one of the most accurate clinical-grade ECG wearable devices.

28 Sep 2018

Critical illness and major infection can promote brain changes, accelerate cognitive decline

Researchers at Johns Hopkins report that a novel analysis of more than a thousand patients adds to evidence that hospitalization, critical illness and major infection may diminish brain structures that are most commonly affected by Alzheimer's disease.

28 Sep 2018

New book provides evidence that new drugs, medical technologies are safe and effective

Does a new medicine or diagnostic test work? Is it safe? Should the government approve it and insurers pay for it? The answers are not as straightforward as they may seem - and the reasons are the subject of a new book by Karen J. Maschke, a research scholar at The Hastings Center, and Michael K. Gusmano, a Hastings Center research scholar and an associate professor of health policy at Rutgers University School of Public Health.

27 Sep 2018

Rutgers study uncovers new mechanism linked to Alzheimer's and traumatic brain injury

Rutgers researchers have discovered a new mechanism that may contribute to Alzheimer's disease and traumatic brain injury. They now hope to launch a clinical trial to test the treatment in humans.

27 Sep 2018

Alzheimer’s disease researchers makes significant breakthroughs

Researchers in Sweden and United Kingdom have made a breakthrough in Alzheimer’s disease research. They could soon be on the path to develop new drugs that could fight the disease more effectively.

26 Sep 2018

UCI study finds new cause of cerebral microbleeds

A team of researchers including UCI project scientist Rachita Sumbria, PhD and UCI neurologist Mark J. Fisher, MD have provided, for the first time, evidence that blood deposits in the brain may not require a blood vessel tear.

25 Sep 2018

Novel drug alleviates memory deficits and neuropathology in Alzheimer's animal model

New research conducted at the Lady Davis Institute at the Jewish General Hospital reveals that a novel drug reverses memory deficits and stops Alzheimer disease pathology in an animal model.

25 Sep 2018

Genervon reports new findings that drug candidate GM6 attenuates Alzheimer's disease in mice model

Following the closure of several research programs for Alzheimer's disease, in early 2018 the FDA issued a release entitled "Draft Guidance for Industry: Early Alzheimer's Disease: Developing Drugs for Treatment." Encouraged by the proposed changes in the new guidance, Genervon's research team reported new findings that its drug candidate GM6 attenuates Alzheimer's disease in an early AD transgenic APP mice model.

25 Sep 2018

Charity urges government to increase financial support for dementia research

Alzheimer’s Research UK, one of the top dementia research funders in the world, is calling on the UK government to adopt a bold new action plan to bring about a life-changing dementia treatment and improve the lives of people with the condition.

25 Sep 2018

Researchers find molecule that halts, reverts neurodegeneration caused by Parkinson's disease

The small SynuClean-D molecule interrupts the formation of the alpha-synuclein amyloid fibers responsible for the onset of Parkinson's disease, and reverts the neurodegeneration caused by the disease.

25 Sep 2018

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Natural nanoscopic particles identified as possible diagnostic tool for Alzheimer's

Newly discovered protein shown to cause amyloid-beta plaques in Alzheimer's

Half of all women are at risk of a stroke, dementia or Parkinson’s disease says study

Study finds disease-causing mutation in French-Canadians

Mediterranean diet cuts risk of developing AMD

More people show interest in getting their DNA tested, finds new poll

Many Alzheimer's patients are taking two or more psychotropic drugs

Up to half of people with Alzheimer's disease use psychotropic drug, finds study

EU countries lack capacity to rapidly move future Alzheimer's treatment into clinical use

SDSU receives $4M grant to boost number of Latino researchers studying Alzheimer's disease

Insilico Medicine collaborates with MAWI to develop multi-modal biomarkers of aging

Critical illness and major infection can promote brain changes, accelerate cognitive decline

New book provides evidence that new drugs, medical technologies are safe and effective

Rutgers study uncovers new mechanism linked to Alzheimer's and traumatic brain injury

Alzheimer’s disease researchers makes significant breakthroughs

UCI study finds new cause of cerebral microbleeds

Novel drug alleviates memory deficits and neuropathology in Alzheimer's animal model

Genervon reports new findings that drug candidate GM6 attenuates Alzheimer's disease in mice model

Charity urges government to increase financial support for dementia research

Researchers find molecule that halts, reverts neurodegeneration caused by Parkinson's disease

Innovation in neuroscience drug discovery - eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in